FDAnews
www.fdanews.com/articles/86586-nymox-pharma-announces-regulatory-milestone-in-europe-for-nicalert-product

NYMOX PHARMA ANNOUNCES REGULATORY MILESTONE IN EUROPE FOR NICALERT PRODUCT

May 5, 2006

Friday, Nymox Pharmaceutical Corp. said it received certification in Europe with the CE Mark for its saliva-based version of its NicAlert product for testing for tobacco use. NicAlert Saliva uses Nymox's patented technology to provide an easy-to-use, on-site visual read-out of an individual's level of tobacco use or exposure.

Trading Markets (http://www.tradingmarkets.com/tm.site/news/BREAKING%20NEWS/246560/)